J7510 HCPCS code: Prednisolone oral, per 5 mg
J7510 is the HCPCS Level II code for prednisolone oral, per 5 mg. In 2024 Medicare paid an average of $0.08 per service for J7510 across 94,495 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 240 per day on DME suppliers. Medicare volume fell 43% from 2022 to 2024 (165,071 to 94,495 services). In 2024, 66 suppliers billed Medicare for J7510 (purchases), serving 396 beneficiaries; Illinois, Michigan, New York accounted for 89% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1996-01-01 |
| Last action effective | 2000-01-01 |
Who bills J7510 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 66 |
| Referring clinicians | 134 |
| Medicare beneficiaries | 396 |
| States with claims | 16 |
| Share of services in top 3 states (Illinois, Michigan, New York) | 89% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 70 | 594 |
| 2023 | 81 | 621 |
| 2024 | 66 | 396 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7510, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 165,071 | 594 | $0.14 | $0.11 |
| 2023 | 158,534 | 621 | $0.14 | $0.10 |
| 2024 | 94,495 | 396 | $0.11 | $0.08 |
States with the most J7510 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 71,820 | $0.05 |
| Michigan | 5,650 | $0.12 |
| New York | 3,024 | $0.08 |
| Texas | 1,990 | $0.23 |
| Missouri | 1,965 | $0.24 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 240 | Clinical: Data |
| outpatient hospital claims | 60 | Prescribing Information |
Medicare policy articles for this code
- A52474: Immunosuppressive Drugs - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
Covered diagnoses (64 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| T86.00 | Unspecified complication of bone marrow transplant | 1 |
| T86.01 | Bone marrow transplant rejection | 1 |
| T86.02 | Bone marrow transplant failure | 1 |
| T86.03 | Bone marrow transplant infection | 1 |
| T86.09 | Other complications of bone marrow transplant | 1 |
| T86.10 | Unspecified complication of kidney transplant | 1 |
| T86.11 | Kidney transplant rejection | 1 |
| T86.12 | Kidney transplant failure | 1 |
| T86.13 | Kidney transplant infection | 1 |
| T86.19 | Other complication of kidney transplant | 1 |
Showing 10 of 64. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J7510
- 1996-01-01: J7510 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7510?
J7510 is the HCPCS Level II code for prednisolone oral, per 5 mg. Short descriptor: "Prednisolone oral per 5 mg".
How much does Medicare pay for J7510?
In 2024, the average Medicare payment was $0.08 per service (average allowed $0.11).
Does Medicare cover J7510?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Which diagnoses support coverage for J7510?
Medicare policy articles that cite J7510 list 64 covered ICD-10-CM diagnosis codes across 1 article. The most cited include T86.00 (Unspecified complication of bone marrow transplant), T86.01 (Bone marrow transplant rejection), T86.02 (Bone marrow transplant failure). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J7510 can be billed per day?
240 on DME suppliers; 60 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7510
- Watch J7510 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7510
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.